Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share Latest Annual | PANACEABIO FY26 | SAIPARENT FY26 | HIKAL FY26 | INDOCO FY26 | Peer Average | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | — | 111.02× | — | — | 111.02× | |
| P/B | 2.42× | 4.36× | ◆ 2.08× | 2.10× | 2.85× -15% | |
| EV/EBITDA | ◆ -420.68× | 52.86× | 14.35× | 20.94× | 29.38× -1532% | |
| Market Cap | ₹2,017 Cr | ₹2,139 Cr | ₹2,496 Cr | ₹1,973 Cr | ₹2,202 Cr -8% | |
| Growth | ||||||
| Revenue CAGR 3Y | ◆ 11.63% | — | -5.40% | 3.41% | -1.00% +1269% | |
| Revenue CAGR 5Y | 0.47% | — | -0.09% | ◆ 8.25% | 4.08% -88% | |
| Revenue YoY (latest Q) | ◆ 19.72% | — | 5.89% | 7.32% | 6.61% +199% | |
| Net Income YoY (latest Q) | -44.44% | — | 66.96% | ◆ 311.40% | 189.18% -123% | |
| Profitability | ||||||
| EBITDA Margin | -0.73% | 10.16% | ◆ 12.87% | 7.68% | 10.24% -107% | |
| Net Income Margin | -1.12% | ◆ 3.74% | -2.85% | -5.35% | -1.49% +25% | |
| Return on Common Equity | -0.64% | ◆ 2.91% | -3.97% | -9.70% | -3.59% +82% | |
| Return on Capital Employed | -4.11% | 2.57% | ◆ 3.30% | 0.97% | 2.28% -280% | |
| Return on Assets | -0.56% | ◆ 1.00% | -1.99% | -3.93% | -1.64% +66% | |
| Credit & Quality | ||||||
| Total Debt/Equity | ◆ 0.03× | 0.65× | 0.57× | 1.11× | 0.78× -96% | |
| Interest Coverage | -6.23× | ◆ 1.18× | 0.91× | 0.13× | 0.74× -942% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹640 Cr | ₹381 Cr | ₹1,713 Cr | ₹1,845 Cr | ₹1,313 Cr -51% | |
| Net Income | −₹7.2 Cr | ₹14.3 Cr | −₹48.8 Cr | −₹98.7 Cr | −₹44.4 Cr +84% | |
| Total Assets | ₹1,262 Cr | ₹1,424 Cr | ₹2,365 Cr | ₹2,593 Cr | ₹2,128 Cr -41% | |
| EPS | ₹-0.88 | ₹4.36 | ₹-3.96 | ₹-10.7 | ₹-3.43 +74% | |
| Book Value per Share | ₹136.19 | ₹111.08 | ₹97.07 | ₹101.76 | ₹103.3 +32% | |